会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • TRIPEPTIDYL PEPTIDASE INHIBITORS
    • TRIPEPTIDYL肽抑制剂
    • WO0236116A9
    • 2003-05-30
    • PCT/EP0112388
    • 2001-10-24
    • JANSSEN PHARMACEUTICA NVBRESLIN HENRY JOSEPHDE WINTER HANS LOUIS JOSKUKLA MICHAEL JOSEPH
    • BRESLIN HENRY JOSEPHDE WINTER HANS LOUIS JOSKUKLA MICHAEL JOSEPH
    • A61K31/4178A61K31/4184A61K31/4196A61K31/4245A61K31/427A61K31/454A61K31/4709A61K31/4725A61P1/00A61P3/04A61P25/18A61P43/00C07D233/64C07D401/04C07D403/04C07D403/12C07D403/14C07D413/04C07D417/04A61K31/404A61K31/422A61K31/47
    • C07D401/04C07D403/04C07D403/12C07D413/04C07D417/04
    • The present invention is concerned with novel compounds of formula (I) which are inhibitors of a membrane tripeptidyl peptidase responsible for the inactivation of endogenous neuropeptides such as cholecystokinis (CCKs). The invention further relates to methods for preparing such compounds, pharmaceutical compositions comprising said compounds as well as the use as a medicine of said compounds. (I) wherein n is an integer (0) or (1); X represents O; S; or -(CR R )m- wherein m is an integer (1) or (2); R and R are each independently from each other hydrogen or C1-4alkyl; R is C1-6alkylcarbonyl optionally substituted with hydroxy; C1-6alkyloxycarbonyl; aminoC1-6alkylcarbonyl wherein the C1-6alkyl group is optionally substituted with C3-6cycloalkyl; mono- and di(C1-4alkyl)aminoC1-6alkylcarbonyl; aminocarbonyl substituted with aryl; C1-6alkylcarbonyloxyC1-6alkylcarbonyl; C1-6alkyloxycarbonylaminoC1-6alkylcarbonyl wherein the amino group is optionally substituted with C1-4alkyl; an amino acid; C1-6alkyl substituted with amino; or arylcarbonyl; R is an optionally substituted (5)-membered heterocycle, or R is optionally substituted benzimidazole; R is a bivalent radical -CH2CH2- optionally substituted with halo or phenylmethyl; or R is a bivalent radical of formula (II).
    • 本发明涉及新型的式(I)化合物,其是负责灭活内源性神经肽如缩胆囊壶菌(CCKs)的膜三肽基肽酶的抑制剂。 本发明还涉及制备这些化合物的方法,包含所述化合物的药物组合物以及用作所述化合物的药物。 (I)其中n为整数(0)或(1); X表示O; S; 或 - (CR 4 R 5)m - ,其中m是整数(1)或(2); R 4和R 5各自独立地为氢或C 1-4烷基; R 1是任选被羟基取代的C 1-6烷基羰基; C1-6alkyloxycarbonyl; 氨基C 1-6烷基羰基,其中C 1-6烷基任选被C 3-6环烷基取代; 单和二(C 1-4烷基)氨基C 1-6烷基羰基; 被芳基取代的氨基羰基; C1-6alkylcarbonyloxyC1-6alkylcarbonyl; C 1-6烷氧基羰基氨基C 1-6烷基羰基,其中氨基任选被C 1-4烷基取代; 氨基酸; 被氨基取代的C1-6烷基; 或芳基羰基; R 2是任选取代的(5)表示的杂环,或R 2是任选取代的苯并咪唑; R 3是任选被卤素或苯基甲基取代的二价基团-CH 2 CH 2; 或R 3是式(II)的二价基团。